A detailed history of Kb Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kb Financial Partners, LLC holds 219 shares of LLY stock, worth $179,345. This represents 0.03% of its overall portfolio holdings.

Number of Shares
219
Previous 177 23.73%
Holding current value
$179,345
Previous $83,000 42.17%
% of portfolio
0.03%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$434.7 - $599.3 $18,257 - $25,170
42 Added 23.73%
219 $118,000
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $42,439 - $56,746
121 Added 216.07%
177 $83,000
Q1 2022

May 17, 2022

SELL
$234.69 - $291.66 $2,112 - $2,624
-9 Reduced 13.85%
56 $16,000
Q4 2021

Feb 18, 2022

BUY
$224.85 - $279.04 $14,615 - $18,137
65 New
65 $18,000
Q3 2021

Nov 16, 2021

SELL
$221.6 - $272.71 $12,409 - $15,271
-56 Closed
0 $0
Q1 2021

Jun 08, 2021

BUY
$164.32 - $212.72 $9,201 - $11,912
56 New
56 $10,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.